5-(2-Oxopropyl)benzo[d]oxazol-2(3H)-one

Catalog No.: 
ACZFCP349
CAS No.: 
1368559-27-6
Molecular Formula: 
C10H9NO3
Molecular Weight: 
191.19
5-(2-Oxopropyl)benzo[d]oxazol-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$74.00In stockInquiry
50mg95%$130.00In stockInquiry
100mg95%$209.00In stockInquiry
250mg95%$483.00In stockInquiry
1g95%$1893.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2-Oxopropyl)benzo[d]oxazol-2(3H)-one
IUPAC Name5-(2-oxopropyl)benzo[d]oxazol-2(3H)-one
MDL No.MFCD21985019
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=C1OC2=CC=C(CC(C)=O)C=C2N1
InChI KeyFZMNVYOYRGXACL-UHFFFAOYSA-N
Synonym2(3H)-Benzoxazolone, 5-(2-oxopropyl)-;5-(2-oxopropyl)benzo[d]oxazol-2(3H)-one
CAS No.1368559-27-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZFCP349 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZFCP349 route product structure diagram
    ACZFCP3491368559-27-6In Stock
Inquiry

2. ACZFCP349 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZFCP349 route product structure diagram
    ACZFCP3491368559-27-6In Stock
Inquiry

3. ACZFCP349 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZFCP349 route product structure diagram
    ACZFCP3491368559-27-6In Stock
Inquiry

Comments (0)